Globalisation

(Image: Getty/BobHemphill)

Takeda sheds products in emerging markets in $200m deal

By Ben Hargreaves

Takeda has sold selected prescription and OTC products to Acino covering its Near East, Middle East and Africa portfolio, as it looks to trim down its portfolio following the acquisition of Shire.

(Image: Getty/NicoElNino)

Ranitidine recalls sweep globe

By Ben Hargreaves

US, Canadian, South Korean, and Indian authorities recommend the recall of certain ranitidine medicines due to cancer-causing impurity.

(Image: Getty/Zozulya)

Torrent expands recall of losartan products, again

By Ben Hargreaves

Torrent announces that it will recall batches of losartan tablets for the sixth time, after the detection of NMBA exceeding acceptable daily intake levels in latest recall.

(Image: Getty/HS3RUS)

POLL

How invested is pharma in sustainability?

By Ben Hargreaves

As a day of climate strikes unfolds across the world, we ask how far pharma is engaged on the issue, as well as noting recent innovations that suggest companies are looking at what can be done.